{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lamivudine : Questions médicales les plus fréquentes",
"headline": "Lamivudine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lamivudine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-10",
"dateModified": "2025-03-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lamivudine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Zalcitabine",
"url": "https://questionsmedicales.fr/mesh/D016047",
"about": {
"@type": "MedicalCondition",
"name": "Zalcitabine",
"code": {
"@type": "MedicalCode",
"code": "D016047",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.685.245.500.950"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lamivudine",
"alternateName": "Lamivudine",
"code": {
"@type": "MedicalCode",
"code": "D019259",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "David Rial-Crestelo",
"url": "https://questionsmedicales.fr/author/David%20Rial-Crestelo",
"affiliation": {
"@type": "Organization",
"name": "Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, CIBERINFEC, Spain."
}
},
{
"@type": "Person",
"name": "Andrés Esteban-Cantos",
"url": "https://questionsmedicales.fr/author/Andr%C3%A9s%20Esteban-Cantos",
"affiliation": {
"@type": "Organization",
"name": "Infectious Diseases Unit, La Paz University Hospital, Instituto de Investigación Hospital Universitario La Paz, Madrid, Spain."
}
},
{
"@type": "Person",
"name": "Paula Aranguren-Rivas",
"url": "https://questionsmedicales.fr/author/Paula%20Aranguren-Rivas",
"affiliation": {
"@type": "Organization",
"name": "HIV Unit, University Hospital 12 de Octubre-Imas12, Madrid, Spain."
}
},
{
"@type": "Person",
"name": "Julen Cadiñanos",
"url": "https://questionsmedicales.fr/author/Julen%20Cadi%C3%B1anos",
"affiliation": {
"@type": "Organization",
"name": "Infectious Diseases Unit, La Paz University Hospital, Instituto de Investigación Hospital Universitario La Paz, Madrid, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Application of Data Fusion in Traditional Chinese Medicine: A Review.",
"datePublished": "2023-12-25",
"url": "https://questionsmedicales.fr/article/38202967",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s24010106"
}
},
{
"@type": "ScholarlyArticle",
"name": "Data on regional availability and accessibility of abortion providers in Germany.",
"datePublished": "2023-12-15",
"url": "https://questionsmedicales.fr/article/39177702",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s43999-023-00036-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Data-Driven Compound Identification in Atmospheric Mass Spectrometry.",
"datePublished": "2023-12-14",
"url": "https://questionsmedicales.fr/article/38095508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/advs.202306235"
}
},
{
"@type": "ScholarlyArticle",
"name": "Confidence estimation based on data from independent studies.",
"datePublished": "2023-12-06",
"url": "https://questionsmedicales.fr/article/38055982",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/09622802231217644"
}
},
{
"@type": "ScholarlyArticle",
"name": "A data catalogue of alcohol dehydrogenases in the genome of a tissue macerating",
"datePublished": "2023-12-06",
"url": "https://questionsmedicales.fr/article/38173983",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.dib.2023.109918"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009705"
},
{
"@type": "ListItem",
"position": 4,
"name": "Nucléosides pyrimidiques",
"item": "https://questionsmedicales.fr/mesh/D011741"
},
{
"@type": "ListItem",
"position": 5,
"name": "Désoxycytidine",
"item": "https://questionsmedicales.fr/mesh/D003841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Zalcitabine",
"item": "https://questionsmedicales.fr/mesh/D016047"
},
{
"@type": "ListItem",
"position": 7,
"name": "Lamivudine",
"item": "https://questionsmedicales.fr/mesh/D019259"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lamivudine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lamivudine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lamivudine",
"description": "Comment diagnostiquer une infection par le VIH ?\nQuels tests pour l'hépatite B ?\nQuels symptômes indiquent une infection par le VIH ?\nComment évaluer la charge virale du VIH ?\nQuels marqueurs pour l'hépatite B chronique ?",
"url": "https://questionsmedicales.fr/mesh/D019259?mesh_terms=Data+Analysis&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lamivudine",
"description": "Quels sont les symptômes de l'hépatite B ?\nQuels effets secondaires de la lamivudine ?\nComment se manifeste une infection par le VIH ?\nQuels signes d'une résistance à la lamivudine ?\nQuels symptômes d'une hépatite B aiguë ?",
"url": "https://questionsmedicales.fr/mesh/D019259?mesh_terms=Data+Analysis&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lamivudine",
"description": "Comment prévenir l'infection par le VIH ?\nQuelles mesures pour éviter l'hépatite B ?\nComment réduire le risque de résistance à la lamivudine ?\nQuel rôle du dépistage dans la prévention ?\nComment sensibiliser à l'hépatite B ?",
"url": "https://questionsmedicales.fr/mesh/D019259?mesh_terms=Data+Analysis&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lamivudine",
"description": "Comment la lamivudine est-elle administrée ?\nQuels autres médicaments avec la lamivudine ?\nQuelle est la posologie de la lamivudine ?\nComment surveiller l'efficacité du traitement ?\nQuels traitements pour l'hépatite B ?",
"url": "https://questionsmedicales.fr/mesh/D019259?mesh_terms=Data+Analysis&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lamivudine",
"description": "Quelles complications de l'hépatite B chronique ?\nQuels risques d'une résistance à la lamivudine ?\nComment la lamivudine affecte-t-elle le foie ?\nQuelles sont les complications du VIH avancé ?\nQuels effets à long terme de la lamivudine ?",
"url": "https://questionsmedicales.fr/mesh/D019259?mesh_terms=Data+Analysis&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lamivudine",
"description": "Quels sont les facteurs de risque du VIH ?\nQui est à risque d'hépatite B ?\nQuel rôle des antécédents médicaux ?\nComment le statut socio-économique influence-t-il le risque ?\nQuels comportements augmentent le risque d'hépatite B ?",
"url": "https://questionsmedicales.fr/mesh/D019259?mesh_terms=Data+Analysis&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le VIH ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin pour détecter les anticorps anti-VIH ou l'ARN du VIH."
}
},
{
"@type": "Question",
"name": "Quels tests pour l'hépatite B ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Tests sanguins pour détecter les antigènes et anticorps de l'hépatite B."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection par le VIH ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes comme fièvre, fatigue, éruptions cutanées, et ganglions enflés."
}
},
{
"@type": "Question",
"name": "Comment évaluer la charge virale du VIH ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par un test sanguin mesurant la quantité d'ARN viral dans le sang."
}
},
{
"@type": "Question",
"name": "Quels marqueurs pour l'hépatite B chronique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Antigène HBs et ADN du virus de l'hépatite B dans le sang."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hépatite B ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, jaunisse, douleurs abdominales, et perte d'appétit."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires de la lamivudine ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, fatigue, maux de tête, et douleurs musculaires."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une infection par le VIH ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infection aiguë avec symptômes grippaux, suivie d'une phase asymptomatique."
}
},
{
"@type": "Question",
"name": "Quels signes d'une résistance à la lamivudine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Échec du traitement, augmentation de la charge virale malgré la prise de médicaments."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une hépatite B aiguë ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes similaires à ceux de la grippe, suivis de jaunisse et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le VIH ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisation de préservatifs, dépistage régulier et traitement préventif."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter l'hépatite B ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination, éviter le partage d'aiguilles et pratiques sexuelles protégées."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de résistance à la lamivudine ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prendre le médicament régulièrement et suivre les recommandations médicales."
}
},
{
"@type": "Question",
"name": "Quel rôle du dépistage dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage précoce permet de traiter rapidement et de réduire la transmission."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser à l'hépatite B ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éducation sur les modes de transmission et l'importance de la vaccination."
}
},
{
"@type": "Question",
"name": "Comment la lamivudine est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par voie orale sous forme de comprimés, généralement une fois par jour."
}
},
{
"@type": "Question",
"name": "Quels autres médicaments avec la lamivudine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent combinée avec d'autres antirétroviraux pour le VIH."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie de la lamivudine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dose standard est de 150 mg deux fois par jour ou 300 mg une fois par jour."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des tests réguliers de la charge virale et des tests de fonction hépatique."
}
},
{
"@type": "Question",
"name": "Quels traitements pour l'hépatite B ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Antiviraux comme la lamivudine, l'entécavir ou l'interféron."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'hépatite B chronique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cirrhose, cancer du foie et insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "Quels risques d'une résistance à la lamivudine ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Échec du traitement et progression de l'infection par le VIH ou l'hépatite B."
}
},
{
"@type": "Question",
"name": "Comment la lamivudine affecte-t-elle le foie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des anomalies des tests hépatiques, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du VIH avancé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections opportunistes, cancers et défaillance multi-organes."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme de la lamivudine ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des effets secondaires chroniques, comme des problèmes hépatiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du VIH ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Relations sexuelles non protégées, partage de seringues et antécédents d'infections."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'hépatite B ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Personnes non vaccinées, utilisateurs de drogues injectables et partenaires sexuels multiples."
}
},
{
"@type": "Question",
"name": "Quel rôle des antécédents médicaux ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Antécédents d'infections ou de traitements peuvent augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Comment le statut socio-économique influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un statut socio-économique faible peut limiter l'accès aux soins et à la prévention."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'hépatite B ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Partage d'aiguilles, relations sexuelles non protégées et manque de vaccination."
}
}
]
}
]
}
Traditional Chinese medicine is characterized by numerous chemical constituents, complex components, and unpredictable interactions among constituents. Therefore, a single analytical technique is usua...
Since 2003, the number of facilities reporting abortions to the Federal Statistical Office has decreased by 46% from 2050 to 1092 in 2021. In the last 5 years, the decrease slowed down. The media repo...
Aerosol particles found in the atmosphere affect the climate and worsen air quality. To mitigate these adverse impacts, aerosol particle formation and aerosol chemistry in the atmosphere need to be be...
The problem of finding confidence intervals based on data from several independent studies or experiments is considered. A general method of finding confidence intervals by inverting a combined test i...
Alcohol dehydrogenases (ADHs) catalyze the oxidation of alcohols and reduction of aldehydes and ketones. Primarily ADHs mitigate aldehydes and alcohol toxicity but they may also perform other function...
Metamaterials are artificial materials designed to exhibit effective material parameters that go beyond those found in nature. Composed of unit cells with rich designability that are assembled into mu...
to reflect on the impacts of the General Personal Data Protection Law on Nursing practice....
reflection article, through the intentional collection of materials relating to the topic....
legislation regulates confidentiality, processing and data sharing, requiring institutional protection measures. The nursing team is responsible for acting preventively, both in care and in the manage...
although the General Personal Data Protection Law requires greater care in relation to data processing, it is established on precepts of good faith and respect for the rights of the individual, concep...
Three dimensional electron back-scattered diffraction (EBSD) microscopy is a critical tool in many applications in materials science, yet its data quality can fluctuate greatly during the arduous coll...
A new kind of data revolution is unfolding around the world, one that is unlikely to be on the radar of tech giants and the power brokers of Silicon Valley. Indigenous Data Sovereignty (IDSov) is a ra...
Drinking water quality data, though regularly monitored, is not available in Germany as national overview, but only decentralized from the water suppliers. On the national level, only the number of li...